Search the Meeting Schedule
Choose from more than 170 Annual Meeting education programs covering the spectrum of neurology. Note: to receive CME for courses attended, program evaluations must be completed online or via the Annual Meeting mobile app.
- 2015 Annual Meeting Registration and Advance Program
- 2015 Scientific Abstract Listing and Annual Meeting Information
- 2015 AAN Annual Meeting Disclosure Information
- Presidential: Tuesday, April 21
9:00 a.m.-12:00 p.m.
Features the AAN's premier lecture awards for clinically relevant research, and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2014.Moderator:
Lisa M. DeAngelis, MD, FAAN, Chair, AAN Science CommitteePresidential Lecture:
Timothy A. Pedley, MD, FAAN
Presidential LectureH. Houston Merritt Lecture:
Daniel H. Lowenstein, MD
Advances in the World of Epilepsy: Really?!?!George C. Cotzias Lecture:
Endowed by Roche Pharmaceuticals.
Stefan M. Pulst, MD, FAAN
Degenerative Ataxias: From Genes to TherapiesSidney Carter Award in Child Neurology Lecture:
Endowed by an anonymous donor.
Brenda Banwell, MD
Multiple Sclerosis in ChildrenRobert Wartenberg Lecture:
Helen S. Mayberg, MD
What Has Deep Brain Stimulation Taught Us About the Neurology of Depression?
- Hot Topics: Tuesday, April 21
5:30 p.m.-6:45 p.m.
Features translational research related to clinical issues of importance. Five outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results.Moderator: Randolph S. Marshall, MD, FAAN
Member, Science CommitteeTherapeutics in Neuromuscular Disease
Brian K. Kaspar, PhD
Nationwide Children’s Hospital, Columbus, OH3-D Cultures for Alzheimer’s Disease
Doo Yeon Kim, PhD
Mass General Institute for Neurodegenerative
Disease, Charleston, MASex-specific Programming of Neurodevelopment by Stress
Tracy L. Bale, PhD
University of Pennsylvania Perelman
School of Medicine, Philadelphia, PARNA-targeted Therapies for Neurologic Disease
Timothy M. Miller, MD, PhD
Washington University School of Medicine
St. Louis, MODigesting the Gut Microbiome: Role in CNS Demyelinating Disease
Lloyd H. Kasper, MD
Dartmouth Medical School, Lebanon, NH
- Contemporary Clinical Issues: Wednesday, April 22
9:00 a.m.-12:00 p.m.
Highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments.Moderator: Lisa M. DeAngelis, MD, FAAN
Chair, Science Committee
Adults with Migraine Have Atypical Correlations between Brain Cortical Thickness and Pain ThresholdsPresenter: Todd J. Schwedt, MD
Mayo Clinic, Phoenix, AZDiscussant: Peter Goadsby, MD, PhD
University of California, San Francisco
San Francisco, CA
AAV9-mediated Gene Therapy in a SMARD1 Mouse ModelPresenter: Stefania Corti, MD, University of Milan
Milan, ItalyDiscussant: Massimo Pandolfo, MD, FAAN
Universite Libre De Bruxelles, Brussels, Belgium
Blood Pressure Control and Risk of Recurrent Lobar Intracerebral HemorrhagePresenter: Christopher D. Anderson, MD, MMSc
Massachusetts General Hospital, Boston, MADiscussant: Kevin N. Sheth, MD, FAHA, FCCM
Yale School of Medicine
New Haven, CT
Invited Speakers:A Decade of Autism Genetics: Building a Foundation for Targeted Treatment Development
Daniel H. Geschwind, MD, PhD
University of California, Los Angeles, Los Angeles, CAGray Zones in the Gray Population: Assessment of Cognition in Late Life
Steven T. DeKosky, MD, FAAN
University of Virginia, Charlottesville, VAPain in a Dish
Brian Wainger, MD, PhD
Massachusetts General Hospital, Boston, MA
- Frontiers in Neuroscience: Thursday, April 23
9:00 a.m.-12:00 p.m.
Focuses on translational research related to clinical issues of importance. Six physician scientists outline their recent research findings, along with the clinical implications.Moderator:
Moderator: Paul M. George, MD, PhD, MSE
Member, Science CommitteeVirginia M-Y Lee, PhD
Transmission of α-Synuclein in Parkinson’s Disease: Pathogenesis and Implications for TherapyKeith A. Josephs, Jr. MD
Antemortem Signatures of Neurodegenerative ProteinopathiesFrancesco Muntoni, MD
Developing Antisense Oligomers as a Genetic Therapy for Duchenne Muscular DystrophyHoward L. Weiner, MD
Immune Mechanisms in Neurologic DiseasesMarco Catani, MD
Towards a New Connectional Anatomy of the Human BrainIngrid Scheiffer, AO, MBBS, PhD, FRACP, FAHMS, FAA
Epilepsy: How Genetic Insights Are Transforming Clinical Practice
- Controversies in Neurology: Thursday, April 23
5:30 p.m.-7:00 p.m.
The program features experts discussing the most current and controversial issues in neuroscience. It is set up as a series of debates in which two speakers argue opposing sides of a single topic, followed by a rebuttal. Each round concludes with a 10-minute question and answer period.
Moderators:Joseph Jankovic, MD, FAAN, Member, Science CommitteeWalter A. Rocca, MD, MPH, Chair, Clinical Research Subcommittee, Member,Science Committee
Should Whole Exome Sequencing be Part of Neurologic Care Today?Pro: Christine Klein, MD, University of Luebeck, Luebeck, GermanyCon: Claes Wahlestedt, MD, PhD
University of Miami Miller School of Medicine
Is the Science of Stem Cells Ready for Clinical Trials in Neurologic Disease?Pro: Clive Svendsen, PhD
Cedars-Sinai Medical Center, Los Angeles, CACon: C. Warren Olanow, MD, FAAN
Mt. Sinai Medical Center, New York, NY
Should Neurologists Prescribe Opioids for Chronic Pain?Pro: Charles E. Argoff, MD
Albany Medical Center, Albany, NYCon: Gary M. Franklin, MD, MPH, FAAN
University of Washington, Seattle, WA
- Clinical Trials: Friday, April 24
12:00 p.m.-1:30 p.m.
This mid-day session covers important clinical topics that affect patient care identified from other society meetings. The latest updates within several clinical trials conducted over the course of the last year will be presented with an open panel discussion at the conclusion.
Moderators:Natalia S. Rost, MD, FAAN, Vice Chair, Science Committee,Petra Kaufmann, MD Member, Clinical Research Subcommittee
Amifampridine Phosphate (FirdapseTM) is safe and Effective in a Pivotal Phase 3 Trial in LEMS PatientsShin J. Oh, MD, FAAN
University of Alabama at Birmingham, Birmingham, AL
Effect of MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of a Pivotal Phase III Randomized Double Blind Placebo Controlled StudyAyman Tourbah, MD, PhD
CHU de Reims, Reims, France
Idebenone Reduces Loss of Respiratory Function in Duchenne Muscular Dystrophy—Outcome of a Phase III Double Blind, Randomised, Placebocontrolled Trial (DELOS)Gunnar Buyse, PhD, MD
University Hospitals K.U. Leuven, Leuven, Belgium
The Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlandsv (MR CLEAN): Update
and Clinical ImplicationsDiedrik Dippel, MD
Erasmus MC University Medical Center, Rotterdam, Netherlands
Phenytoin is neuroprotective in acute optic neuritis: Results of a phase 2 randomized controlled trial.Raju Kapoor, MD
National Hospital, London, United Kingdom
- Neurology Year in Review: Friday, April 24
4:30 p.m.-6:00 p.m.
This plenary session will feature six speakers, each focusing on the latest research that has happened in the last year within a specific subspecialty topic.Moderator:Lisa M. DeAngelis, MD, FAAN
Chair, Science Committee
Memorial Sloan-Kettering Cancer Center, New York, NYMovement Disorders
Michael S. Okun, MD, FAAN
University of Florida, Gainesville, FLNeuro-rehabilitation
Bruce H. Dobkin, MD, FAAN
University of California, Los Angeles, Los Angeles, CAVertigo
David Newman-Toker, MD, PhD, FAAN
Johns Hopkins University School of Medicine, Baltimore, MDPediatric Neurology
Nina F. Schor, MD, PhD
University of Rochester Medical Center, Rochester, NYMultiple Sclerosis and Neuromyelitis Optica
Jeffrey Allan Cohen, MD
Cleveland Clinic, Cleveland, OH
Invited Science Sessions
The AAN is partnering with the American Heart Association, the American Stroke Association, and the American Epilepsy Society to bring you science previously presented at the subspecialty conferences. Cutting-edge abstracts will be presented by their authors in 20-minute platform sessions.
- Leadership for Women
- Become an influential leader for your patients and profession on Sunday, April 19, 2015. Leadership for Women is designed for early to mid-career women who want to prepare for greater leadership roles. Apply today!
- Advanced Leadership for Women
- The Monday, April 20, 2015, program designed for mid-career women currently in leadership roles and want to grow their leadership capacity. Apply today!
- Improving your leadership: a practical approach
- The Monday, April 20, 2015 course will assist you in implementing the vision and offer practical tips and case examples on how to persuade others to follow. Learn More.